Clinical Trial Update: Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Plerixafor plus G-CSF for mobilization and collection of peripheral hematopoietic stem cells in Japanese patients with multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)
• Plerixafor (Plerixafor)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED